|Bid||144.02 x 900|
|Ask||0.00 x 800|
|Day's range||143.70 - 144.29|
|52-week range||109.16 - 157.00|
|Beta (5Y monthly)||0.69|
|PE ratio (TTM)||22.68|
|Earnings date||26 Jan 2021|
|Forward dividend & yield||4.04 (2.78%)|
|Ex-dividend date||23 Nov 2020|
|1y target est||166.18|
The World Health Organization is managing a global vaccine program without U.S. participation, and it could have a big impact for investors.
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has a knack for making himself, and his shareholders, a lot of money. Since 1965, Berkshire Hathaway stock has averaged a compound annual gain of 20.3%, which works out to an aggregate gain of 2,744,062% over the past 55 years. While investors often point to the Oracle of Omaha's ability to find value in plain sight, as well as his focus on businesses with sustainable competitive advantages, maybe the most important puzzle piece to Buffett's success has been his willingness to buy great companies and hold them for very long periods of time.
In this Fool Live video, Healthcare and Cannabis Bureau Chief Corinne Cardina and longtime Motley Fool contributor Keith Speights discuss several investing strategies to potentially profit from coronavirus vaccine stocks. Corinne Cardina: I'm going to ask you about strategies for investing in the coronavirus vaccine. You could buy a basket with some of the phase three companies that one from each of the different vaccine technologies.